At Currax, we are committed to advancing healthcare through our clinical trials program. Our dedicated teams work tirelessly to ensure that our trials are conducted with the highest standards of scientific rigor and ethical care. Our trials are open to individuals who meet the eligibility criteria and are interested in contributing to the advancement of medical science and patient care.

Active

Protocol ID	Title	Indication	Phase	Additional Information
NB-CVOT3 (INFORMUS)	A Study to Assess the Effect of Naltrexone Hydrochloride Extended Release (ER) and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on the Occurrence of Major Adverse Cardiovascular Events	Obesity, Adult	Phase 4	https://clinicaltrials.gov/study/NCT06098079

In Development

Product	Indication	Phase
Naltrexone Hydrochloride Extended Release (ER) and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®)	Obesity, Adolescent	Phase 3
Naltrexone Hydrochloride Extended Release (ER) and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®)	Obesity, Pediatric	Phase 3
Breath Powered® Nasal Sumatriptan (ONZETRA® Xsail®)	Migraine, Adolescent	Phase 3